![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 06, 2005 7:07:15 PM
Selective vision by doug and matt and the immaturity of many posters herein have promoted my increasing presence. Enjoy.
The accompanying consolidated financial statements of DNAPrint genomics, Inc.
and Subsidiary have been prepared assuming that the Company will continue as a
going concern. As more fully described in Note B, the Company has had recurring
operating losses since inception, has negative working capital as of December
31, 2004, and has used approximately $3,764,000 of cash in operations for the
year ended December 31, 2004. These conditions raise substantial doubt about the
Company's ability to continue as a going concern. Management's plans regarding
these matters are also described in Note B. The consolidated financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3370094
There comes a time when you define the moment, or the moment defines you. - Tin Cup
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM